Dynamic and results-driven leader with over 15 years of experience in portfolio and program management within the medical device and biopharma industries. Proven expertise in establishing and scaling Portfolio Program Management Offices (PPMOs), leading strategic initiatives, and delivering innovative solutions that align with organizational goals. Key contributor to the first FDA approval for a liquid biopsy NGS assay (Guardant360 CDx) and creator of the biopharma development services portfolio within the oncology portfolio. Key leader in bolstering the minimum residual disease (MRD) portfolio and launching, transferring products across platforms. Adept at navigating high-growth environments, fostering cross-functional collaboration, and driving clinical and biopharma program success.
Product Manager Accomplishments
Portfolio Program Management
Resource Management
Program Governance
Program Management
Long Range Planning
Team Building
Building Best Practices
Department Budgeting
Strategic leadership
Accomplishments for which I had a Portfolio or Program leadership role in from 2019 to the present:
Project Management
References can be provided upon request.
Project Management
Marketing Innovation Certificate - MIT Sloan
CE Marketing for Medical Devices, IVDs, and AIMS - Noblitt & Rueland
Process Validation for Medical Devices - Noblitt & Rueland